Literature DB >> 26659208

Development and Validation of a PCR Assay To Detect the Prairie Epidemic Strain of Pseudomonas aeruginosa from Patients with Cystic Fibrosis.

M Workentine1, A Poonja2, B Waddell2, J Duong3, D G Storey4, D Gregson5, R Somayaji5, H R Rabin5, M G Surette6, M D Parkins7.   

Abstract

The monitoring of epidemic Pseudomonas aeruginosa is important for cystic fibrosis (CF) infection control. The prairie epidemic strain (PES) is common in western Canadian CF clinics. Using whole-genome sequencing, we identified a novel genomic island and developed a PCR assay for PES. Against a collection of 186 P. aeruginosa isolates, the assay had 98% sensitivity and 100% specificity.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2015        PMID： 26659208      PMCID： PMC4733202          DOI： 10.1128/JCM.02603-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Diagnostic multiplex PCR assay for the identification of the Liverpool, Midlands 1 and Manchester CF epidemic strains of Pseudomonas aeruginosa.

Authors:  Joanne L Fothergill; Anna L Upton; Tyrone L Pitt; C Anthony Hart; Craig Winstanley
Journal:  J Cyst Fibros       Date:  2007-10-29       Impact factor: 5.482

2.  Assembling single-cell genomes and mini-metagenomes from chimeric MDA products.

Authors:  Sergey Nurk; Anton Bankevich; Dmitry Antipov; Alexey A Gurevich; Anton Korobeynikov; Alla Lapidus; Andrey D Prjibelski; Alexey Pyshkin; Alexander Sirotkin; Yakov Sirotkin; Ramunas Stepanauskas; Scott R Clingenpeel; Tanja Woyke; Jeffrey S McLean; Roger Lasken; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2013-10       Impact factor: 1.479

3.  Infection prevention and control guideline for cystic fibrosis: 2013 update.

Authors:  Lisa Saiman; Jane D Siegel; John J LiPuma; Rebekah F Brown; Elizabeth A Bryson; Mary Jo Chambers; Veronica S Downer; Jill Fliege; Leslie A Hazle; Manu Jain; Bruce C Marshall; Catherine O'Malley; Suzanne R Pattee; Gail Potter-Bynoe; Siobhan Reid; Karen A Robinson; Kathryn A Sabadosa; H Joel Schmidt; Elizabeth Tullis; Jennifer Webber; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2014-07-01       Impact factor: 3.254

4.  Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.

Authors:  S J McCallum; J Corkill; M Gallagher; M J Ledson; C A Hart; M J Walshaw
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

Review 5.  Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Ian J Clifton; Daniel G Peckham
Journal:  Expert Rev Respir Med       Date:  2010-08       Impact factor: 3.772

6.  Development of a diagnostic test for the Midlands 1 cystic fibrosis epidemic strain of Pseudomonas aeruginosa.

Authors:  Catherine H M Smart; Fiona W Scott; Elli A Wright; Martin J Walshaw; C Anthony Hart; Tyrone L Pitt; Craig Winstanley
Journal:  J Med Microbiol       Date:  2006-08       Impact factor: 2.472

7.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

8.  IslandViewer update: Improved genomic island discovery and visualization.

Authors:  Bhavjinder K Dhillon; Terry A Chiu; Matthew R Laird; Morgan G I Langille; Fiona S L Brinkman
Journal:  Nucleic Acids Res       Date:  2013-05-15       Impact factor: 16.971

9.  Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.

Authors:  C E Wainwright; M W France; P O'Rourke; S Anuj; T J Kidd; M D Nissen; T P Sloots; C Coulter; Z Ristovski; M Hargreaves; B R Rose; C Harbour; S C Bell; K P Fennelly
Journal:  Thorax       Date:  2009-07-01       Impact factor: 9.139

10.  Successful implementation of infection control strategies prevents P. aeruginosa transmission among cystic fibrosis patients inside the hospital.

Authors:  Benedikt Matt; Dieter Mitteregger; Sabine Renner; Elisabeth Presterl; Ojan Assadian; Magda Diab-Elschahawi
Journal:  GMS Hyg Infect Control       Date:  2014-09-30
View more
  3 in total

Review 1.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

2.  Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities.

Authors:  Nicole Acosta; Barbara Waddell; Alya Heirali; Ranjani Somayaji; Michael G Surette; Matthew L Workentine; Harvey R Rabin; Michael D Parkins
Journal:  Front Cell Infect Microbiol       Date:  2020-04-24       Impact factor: 5.293

3.  Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.

Authors:  R Somayaji; B Waddell; M L Workentine; M G Surette; N P Brager; H R Rabin; M D Parkins
Journal:  BMC Pulm Med       Date:  2015-11-05       Impact factor: 3.317
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.